Detection of somatic mutations of the bcl-2 oncogene in B cell lymphomas with the t(14;18)

International Journal of Oncology

Volumn 11, Issue 3, 1997, Pages 481-488

  Pappa, V I ^a   Wilkes, S ^a   Norton, A ^a   Phillips, S ^a   Rohatiner, A Z S ^a   Lister, T A ^a   Young, B D ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Bcl 2; Follicular lymphoma; Somatic mutation

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MISSENSE MUTATION; NONHODGKIN LYMPHOMA; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 0030804781     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.3.481     Document Type: Article

References (25)

1. Offit K, Wong G, Filippa PA, Tao Y and Chaganti RSK: Cytogcnctic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 77: 1508-1515, 1991.
2. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A and Arnesen M: Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 316: 79-84, 1987.
3. Fukuhara S, Rowley JD, Varrakojis D and Colomb HM: Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 39: 3119-3128, 1979.
4. Clearly ML, Smith SD and Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47: 19-28, 1986.
5. Bakshi A, Wright JJ, Graninger W, Seto M, Owens J, Cossman J, Jensen JP, Goldman P and Korsmeyer SJ: Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84: 2396-2400, 1987.
6. Cleary ML, Galili N and Sklar J: Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164: 315-320, 1986.
7. Ngan B-Y, Nourse J and Cleary ML: Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 73: 1759-1762, 1989.
8. Dyer MJS, Zani VJ, Lu WZ, O'Byrne A, Mould S, Chapman R, Heward JM, Kayano H, Jadayel D, Matutes E, Catovsky D and Oscier DG: Bcl-2 translocations in leukemias of mature B cells. Blood 83: 3682-3688, 1994.
9. Mufti GJ, Hamblin TJ, Oscier DG and Johnson S: Common ALL with pre-B cell features showing (8;14) and (14;18) chromosome translocations. Blood 62: 1142-1146, 1983.
10. Thangavelu M, Olopade O, Beckman E, Vardiman JW, Larson RA, McKeithan TW, Le Beau MM and Rowley JD: Clinical, morphological and cytogenetic characteristics of patients with lymphoid malignancies characterised by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11). Genes Chromosom Cancer 2: 147-158, 1990.
11. Lillington-DM, Monard S, Johnson PWM, Evans ML, Kearney LU, Lister TA, Young BD and Gibbons B: The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9). Leukemia 8: 560-563, 1994.
12. Nacheva E, Dyer MJS, Fischer P, Stranks G, Henard JM, Marcus RE, Grace C and Karpas A: C-myc translocations in de novo B-cell lineage acute leukemias with t(14;18) (Cell Line Karpas 231 and Karpas 353). Blood 82: 231-240, 1993.
13. Limpens J, de Jong D, van Krieken JHJM, Price CGA, Young BD, van Ommen G-JB and Kluin PM: bcl-2/IgH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6: 2271-2276, 1991.
14. Gupta RK, Whelan JS, Lister TA, Young BD and Bodmer JG: Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease. Blood 79: 2084-2088, 1992.
15. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP and Korsmeyer SJ: Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-88, 1989.
16. McDonnell TJ, Nunez G, Platt FM, Hockenberg D, London L, McKearn JP and Korsmeyer SJ: Deregulated bcl-2 immunoglobulin transgene expands a resting but responsive immunoglobulin M and D expression B cell population. Mol Cell Biol 10: 1901-1907, 1990.
17. McDonnell TJ and Korsmeyer SJ: Progression' from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254-256, 1991.
18. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990.
19. Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalise pre-B cells. Nature 335: 440-442, 1988.
20. Nunez G, London L, Hockenberg D, Alexander M, McKearn J and Korsmeyer SJ: Deregulated bcl-2 gene expression, selectively prolongs survival of growth factor deprived hamopoietic cell lines. J Immunol 144: 3602-3610, 1990.
21. Marvel J, Perkins GR, Rivas AL and Collins MKL: Growth factor starvation of bcl-2 overexprcssing murine bone marrow cells, induced refractoriness to IL-3 stimulation of proliferation. Oncogene 9: 1117-1122, 1994.
22. Miyashita T and Reed JC: Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52: 5407-5411, 1992.
23. Lotem J and Sachs L: Regulation by bcl-2, c-myc and p53 susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective mycloid leukemic cells. Cell Growth Differ 4: 41-47, 1993.
24. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
25. Yin C, Knudson CM, Korsemeyer SJ and van Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640, 1997.